{"name":"Integrative Research Laboratories AB","slug":"integrative-research-laboratories-ab","ticker":"","exchange":"","domain":"integrativeresearchlaboratoriesab.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxORV9rNzJNLWJ2WWxXTktiM05GaUE3a3k2Z3dub2hlREZWUGdvVDBNT05Xbmh2U1lUWmFfMzFHaHhJY1Rhb2FmNWx6M3hwNW54YXQxeEZ3UFE1U1AyNy1JUVM4TTVLYVdEdGpkenJpaUZ1a2tyLUh6LWhMRGJjZVF5LUtVWmRPVTBVaXNKNXpTU2dNck5OaE1raVRYd1dwUXh4alRsemtURkZJc0VlUE1SdmpSYVpsZE16eXFuV3llaURzSVJ3MUtRYy1yYWFEaFJKZG42YndSbmhOV0U?oc=5","date":"2025-04-22","type":"pipeline","source":"prnewswire.com","summary":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight - prnewswire.com","headline":"XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPMW5Cbm9rTXB2Z3FIVEpGcmwzM1dBZ3pQY3Z4aG1oTEJMZVhMWTBwdU5vWDdpdDhDM0VqaXFFd1VFMEtSOU5fSmF0X3VzM09WZEdhQkl3cWVGTDdrRVdjTGhIRU03akRPM29UX3VzTjVMLTFrb0xUZ3cwcWgyU2tnZ0tBTEQzNkl2U3lrR0hGWWd0bkhaSFRPWmhaOFNTYXBuM0Z1ZW1QMlBISnR6WHlNUlFJVUp0T3pMMDdvRHcySFVXVExhd0VvanEyNWZNTF9LdE9ERTZuRUpqVkdfUzhFMkJ4VDQ5OUpvX1Npd1ZyNHpjTnVqZFlNYkE5U1N3MlVXYzBpd2hlNA?oc=5","date":"2025-03-03","type":"pipeline","source":"GlobeNewswire","summary":"LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight - GlobeNewswire","headline":"LEQEMBI Market Sales Reflect Growing Confidence in Disease-Modifying Alzheimer’s Treatments| DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNbjJpMUlyUXpZeHFYNUlhNDJBbWp4TXdxN3ZwZ1E5UHh6Q3lVWUhIa01QOU10VWFHWXhwTUpWZ19EV1Z3QW9EakJOUVpuUUFmREdHQnVWS3ZRN2I4WF9HVDZfODloVTg4ZTMwWG9wMUNnbEU1N1haNkJOQXRpUV9lWWVmdk1fYlpCbTlTUUtxczBObTNibWotTm9iRUFTOGpIbFpDM3BwbklBRExmUHB2d1Bialpaa1lNa1N2WnJmNzltTVFSVldfem1la3VXMG5YbkRPMlBBMVdnOHZ6MzVwWWhhWHByZ29UZ25hUnVBLWdYMWZ2OXZMVDlaZXdBdl8tSVBB?oc=5","date":"2025-02-17","type":"pipeline","source":"prnewswire.com","summary":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight - prnewswire.com","headline":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQdzNUZFRCTVhoSUllbW1XakkxWEZseVhpUVpUMldwNkhMSGZSR0EtYlFZdTREMG5hVUpPWDRwMEJfNW94eU1JbzdXeUVubkl5MnZtUFZLWTMzME9kbW9yTnFkVWdtQjJLRjVBdWtxeHMyTDh6Rk5peXNDaHUxSWthampFTVdfbVowNExVUmFvMnpOYjlsVGs1MmpLbHlvbW56RmlBOE5zVnZzY2VVYnlrU2dST0k5RmVGTU9GdVI5eDBDd1lURE1vU2tBV1ZuR1lwUzNwanBWS29uNW5qZVVaVGtvT1VkdXVkU2swQlQxQVgtNWVkdk95UEVJUVRycDAzNk9mSjl0b1RZaXV1cGxzSlg1bUE3Q3FTWmVLVFgzWW9YQ2M5amNaeQ?oc=5","date":"2025-02-13","type":"trial","source":"GlobeNewswire","summary":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel - GlobeNewswire","headline":"Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxNZllSd2g1blhpVWJucGRwZ2ZFMTQ2Y2FPZ0E1NHppVzU5S1I0STBWZ1ZjblFxMXBXVHVXelhXTDF3OWd1MnlPR1ExMEFhYV9rbC02OUw3UjJRM1lJV2lyVUNORFFzR3NCZWxCeUVsYXdLTVR1UzIzQ1JQdnNvdGZaYVhqMHVOYWFSNFh5M3RXWVI4NlBRX0JKY29FbldKSUVoRk9XZU1VZXJQNFlfNjFBV2dORGVOQk9VUkdoS1JuQkd2SWcwX3RlbnUtZl9rbG9NZkNScFpGZkx6RzBGNEpsbjluQmlOejU2ZGhRSXpnS3Q0WUpQWTN2MGNUTkREbTUyQXJXdGJpY1I5YjV6N2VyenFLelZ2U2RzZ0RnSjEzQWlJbXNIRFhZcHREX0hweXNO?oc=5","date":"2024-12-12","type":"pipeline","source":"GlobeNewswire","summary":"Parkinson's Disease Market is Expected to Showcase a - GlobeNewswire","headline":"Parkinson's Disease Market is Expected to Showcase a","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9DVmJNZUd5R09vRWRwYXRWN1Z3a2NNOTZ6aHpWRW1ma0pxaHV5MWVMS2MxT2dFUGk1RTFLdVNNNy1qR1hYRmxLZmUzeXNjTWpxNVpEWmdERmNkZjhjVTVR?oc=5","date":"2024-11-21","type":"pipeline","source":"nature.com","summary":"Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction - nature.com","headline":"Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxNR3JCQnhRWFJKakk0Ykwxd25Za2xkR2lvY1ZPbGNUR29BaDZiaHZ5TWRZbmxUUm9RaXNPWFNjaFduVUw5NHBZRmZWQ01KYnUwNlVlRzg3UFVZcWJ4eFpzNHk1VGZLNDd4OWwzUllQRkIyZFNsVzB5UDBNd3Q3OGFMQllCR2NDczdtaXhETmhhM0swQ2oxT1NRRnlvdkRQbzRGLWFJX3BqTXRXcHQya3ctdFJEYlc0YlAwdFo0bW1TMFNTQUhSb01scmI2SFYwN3RISDhRUU9yazBLWklLMU9nbEJINGdaa3QtdTh3d0dYdHVnY3R1b2FEZDFWcGk2YkdqX25yOVVNUC1xOVRVWDVKcl80NGgwc0ZwZW9MLUJLYjFmWkl6T1NOT1hXQ1h4eVlNNTVLVU9pWDB4bFBLVUdiSEMzT0wyZ0ZVMERyTmdYanlXWGhwbGc?oc=5","date":"2024-11-13","type":"trial","source":"GlobeNewswire","summary":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire","headline":"NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQaHVqSXFvY2lvRTMxZWFmU293SFBoVGpOeXZQSmxkT0NScTZWc3VTUmcwS3FKajRYS1o5UjZoSGRjZEVSNjhUYjF5a0o1N2ZQcDhSV25ZVUhEQ1dzdDR5VmhOaFl2TjNfOG1nNEZFQ0R0SzJuTzRrZU5YckExYUVnNWwwNnpQNXlqSC1zMDFORXE4Vk5mOHBsbnhEQVgxVVY1bkw5WC14aWdnU04zaWx6MVBHbUk3TWJ5bzV5eHdvSVR5SkRqaVR2c29MTDlnT2pPbi1yMDZ2aWlRTDdwWVpV?oc=5","date":"2024-10-30","type":"pipeline","source":"prnewswire.com","summary":"Global Neurological Biomarkers Market to Surpass USD 16 Billion Mark by 2030 | DelveInsight - prnewswire.com","headline":"Global Neurological Biomarkers Market to Surpass USD 16 Billion Mark by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gJBVV95cUxQUGx5Nnc2U2laS20yUFdZSFh3ekpCN2Y2aUI0M1pPajZnYVlySy1RTktGRzBEUmlGay04c0hWUDN0Tm9WWGF4dVMxdlpEX2FMLWhVSHd3N1c4bWxuMkRyck91Z1hSeVBmS2pkQ0U2dnpDb2VXVF9yNERJUTBIZEFBY2tyNUpVWm5wdmNVQUdqbzc1S0pNUmlRQ2tKWFNuTjJyUWtVblRpaEtSV3lIWE1ZSFZSaFRWMi05NEk3VE9MLUZ4U2VkSDN4UTlwQkZxeXJsZnVIM0ZxWjh4STZfM2puRDhGZTI1Rmg5YlFrVHk1WnZxaGVldjNpTDJKZUxsRVEyX1FFeVVnQXdveTJ1RHdBalBxcTN0LUYyelhINXhHLWtaMG4wSnFBSnd4Q0dJbTJsckVvN2NCbEw4VG1lSndldTlEajZDOTZTb2hBQm1ybGxMU1pwSmI1RWkxd192aldTNGc?oc=5","date":"2024-10-09","type":"trial","source":"prnewswire.com","summary":"Cell and Gene Therapy in Parkinson's Disease Clinical Trial Pipeline Analysis Demonstrates 18+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - prnews","headline":"Cell and Gene Therapy in Parkinson's Disease Clinical Trial Pipeline Analysis Demonstrates 18+ Key Companies at the Hori","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxOVk8yNlBRdDhPT3JXd2hZTTlwLUhuXzRvYlhhWFJudUpXaWlRbWl4WV9RbjVLVUpDVlI1TmRUaF8waHVnQUl0UXN6Y1Z4NGJaQTJSTHR5VzJ5VDJ0TzlCUWpTR0xGWjg5UVhtMG8wNUplTVR5LTZ6b2k1bno0MXEzWnNObDdOdE1xWGRVaGtvUkRLOTF1TjhZWkJCdnMtTmtmTjlzSVd4bkpheEJzajdoRkxETnVmZmhQRkRFUExhV2F3dmJsUWVMd3BZREhEcXdrWFg1cVFTZWMtTk9vdmhMSlZSRGtLQVBjVllfQTlXYnhnY3RkRkJJZS1hSlVWWm1Kb3FzcGRLajljSlUxWmwydXhLVC1ZdWI5eGt5emp1eFhwMmIy?oc=5","date":"2024-07-22","type":"pipeline","source":"GlobeNewswire","summary":"Cell and Gene Therapy in Parkinson's Disease Market to - GlobeNewswire","headline":"Cell and Gene Therapy in Parkinson's Disease Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQWVNLVU5vQnpEU1NqcUk2d0Rib3lLZUhrT2JoVnR3Ti00bWFsVUc0SXJnVUVKbkJJZEJRYmNvc0FIQmN1ZXdjTFY1dWxFUmpGRGhlODhTWE1pOHpjSk02dzdqdHpEQkRSajdGZUpSMEdUbmQ3cVVDeGNQd1Qyc3h3cFhQdUh1b2FvYmxoVzBQa29aWTJhNVJVd2psZjllRUlVUkxLaUdCcnVHNGh5Y0QzNGN4NXRpNjJjNi0zWEl3cjlRZGg0UDRBX29SUHl0YVM3Vmx2ZXdGT0o5VkZo?oc=5","date":"2024-07-08","type":"regulatory","source":"prnewswire.com","summary":"Eli Lilly's Donanemab Approval Heats Up Alzheimer's Disease Treatment Market | DelveInsight - prnewswire.com","headline":"Eli Lilly's Donanemab Approval Heats Up Alzheimer's Disease Treatment Market | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNeDdqQ05ZcVhNR3FNSGg0TnR6UHJhckRJTnhPbmdkV0xUZWhiRjdmZUREdnlhbjRsZTJVaEdwUHVBMmp5N3lMckZqVVd2ZkxWX3pYOUpqdTUwUGlFRGxpcndPd1JpeTZ1dUJEbm16RlRMTmNCdk5jODFCNG1QOFRzNi1vVm9oMUhoVFJlSkc3UlI1cVdsMWxxdzBGeTFxN2F1eVVJbURHQU04SEdRSzVsS3k1UFVLc2dmQzJyRko4RlVrNW9jTTVBeXhObWhFUTRJTEtKTy1wQVJvTGpvVklqNm5jQU9qdkNSbWJKc0FHdFZlcXMtdHotdUt6ZG9hcEluWEN6YWx5cFg4bTh2TkdJRFhMWjBTMkc0c1pNX2l1Y1daU3BicnJLRWtBdjA?oc=5","date":"2023-04-19","type":"trial","source":"prnewswire.com","summary":"Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Working in the Domain | DelveInsight - prnewswire.com","headline":"Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Workin","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}